Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)

Ginsberg, H. N., & Goldberg, I. J. (2023). Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3). Arteriosclerosis, Thrombosis, and Vascular Biology, 43(3), 388–398. https://doi.org/10.1161/atvbaha.122.317966
Authors:
Henry N Ginsberg
Ira J Goldberg
Affiliated Authors:
Henry N Ginsberg
Columbia Affiliation:
Subjects:
Angiopoietin-Like Protein 3 (MeSH)
Dyslipidemias (MeSH)
Author Keywords:
angiopoietin-like protein 3
apolipoprotein c3
cardiovascular disease
dyslipidemia
triglycerides
elink
Publication Type:
Article
Unique ID:
10.1161/atvbaha.122.317966
PMID:
36579649
DOI:
10.1161/atvbaha.122.317966
Journal:
Arteriosclerosis, Thrombosis, and Vascular Biology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: